Role of soluble Fas ligand in autoimmune diseases

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

216

HTML

2288

Figures (1-8)

125

Tables (1-1)

140

Sum=2769

Nov 1, 2004 (publication date) through Jul 7, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Nov 1, 2004; 10(21): 3151-3156
Published online Nov 1, 2004. doi: 10.3748/wjg.v10.i21.3151

Full Size Figure Download Figure

Figure 5 Cell apoptosis induced by different doses of sFasL (25, 50 and 100 μg/L).

Citation: Li NL, Nie H, Yu QW, Zhang JY, Ma AL, Shen BH, Wang L, Bai J, Chen XH, Zhou T, Zhang DQ. Role of soluble Fas ligand in autoimmune diseases. World J Gastroenterol 2004; 10(21): 3151-3156
URL: https://www.wjgnet.com/1007-9327/full/v10/i21/3151.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i21.3151